Compare Moderna, Inc. (MRNA) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs VanEck Semiconductor ETF — how do they compare? Moderna, Inc. trades at $225 (market cap $78.65B), while VanEck Semiconductor ETF trades at $603.33 (market cap $73.92B). The key difference: Moderna, Inc. and VanEck Semiconductor ETF are close in size by market cap, and Moderna, Inc. is trading nearer its 52-week high, VanEck Semiconductor ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and VanEck Semiconductor ETF for 101 Days on average.
| MRNA | SMH | |
|---|---|---|
Market Cap | $78.65B | $73.92B |
Volume | 37,373,437 | 11,050,892 |
Sector | Health | — |
52-Week High | $225.00 | $668.91 |
52-Week Low | $22.36 | $325.10 |
Typical Hold Time | 59 Days | 101 Days |
Enterprise Value | $74.80B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $197.00, up 0.26% today, reflecting a strong 2026 rally. The stock is technically bullish, with moving averages signaling strength and key support at $194. Fundamentally, revenue has declined from pandemic peaks to $1.92 billion in 2025, with net losses widening to -$2.82 billion, though recent quarters have beaten EPS estimates. The company's inclusion in the Nasdaq-100 index effective October 9, 2026, adds a positive catalyst. Analyst sentiment is mixed, with a consensus price target of $115.70 but a high target of $245.00, indicating divergent views on valuation after the stock's significant run-up.
The outlook for Moderna hinges on its pipeline beyond COVID-19, particularly cancer vaccines, but high valuation ratios (P/S of 35.08) and persistent losses pose risks. Upside potential exists if new products gain traction, yet investors face volatility from clinical trial outcomes and competitive pressures. The stock's proximity to 52-week highs suggests caution amid profit-taking signals from some analysts.
SMH (VanEck Semiconductor ETF) trades at $606.82, down 2.91% on the day but maintains a bullish technical outlook with strong moving average support. The semiconductor sector shows robust performance with the ETF up approximately 69% year-to-date through September 2026, significantly outpacing the broader market. Recent industry developments include AMD's $8.2 billion acquisition of World Labs, expanding AI capabilities across the semiconductor ecosystem.
The semiconductor sector's structural growth driven by AI adoption presents continued upside potential, though concentration risk in top holdings like Nvidia and cyclical industry volatility remain key considerations. Technical support at $597 and resistance at $620 define near-term trading ranges, with the overall bullish trend supported by strong sector fundamentals and institutional interest.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
